Recordati Industria Chimica e Farmaceutica S.p.A.

BIT:REC Stok Raporu

Piyasa değeri: €10.8b

Recordati Industria Chimica e Farmaceutica Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 3/6

Recordati Industria Chimica e Farmaceutica has been growing earnings at an average annual rate of 1.1%, while the Pharmaceuticals industry saw earnings growing at 13.1% annually. Revenues have been growing at an average rate of 9.7% per year. Recordati Industria Chimica e Farmaceutica's return on equity is 21.4%, and it has net margins of 17.4%.

Anahtar bilgiler

1.1%

Kazanç büyüme oranı

1.0%

EPS büyüme oranı

Pharmaceuticals Sektör Büyümesi12.4%
Gelir büyüme oranı9.7%
Özkaynak getirisi21.4%
Net Marj17.4%
Sonraki Kazanç Güncellemesi08 Nov 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC) Not Flying Under The Radar

Oct 31
Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC) Not Flying Under The Radar

Estimating The Fair Value Of Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)

Sep 07
Estimating The Fair Value Of Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)

We Think Recordati Industria Chimica e Farmaceutica (BIT:REC) Can Stay On Top Of Its Debt

Aug 20
We Think Recordati Industria Chimica e Farmaceutica (BIT:REC) Can Stay On Top Of Its Debt

Earnings Miss: Recordati Industria Chimica e Farmaceutica S.p.A. Missed EPS By 31% And Analysts Are Revising Their Forecasts

Aug 02
Earnings Miss: Recordati Industria Chimica e Farmaceutica S.p.A. Missed EPS By 31% And Analysts Are Revising Their Forecasts

Recordati Industria Chimica e Farmaceutica S.p.A.'s (BIT:REC) Business Is Yet to Catch Up With Its Share Price

Aug 01
Recordati Industria Chimica e Farmaceutica S.p.A.'s (BIT:REC) Business Is Yet to Catch Up With Its Share Price

Estimating The Intrinsic Value Of Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)

May 26
Estimating The Intrinsic Value Of Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)

Recordati Industria Chimica e Farmaceutica (BIT:REC) Will Pay A Larger Dividend Than Last Year At €0.63

May 10
Recordati Industria Chimica e Farmaceutica (BIT:REC) Will Pay A Larger Dividend Than Last Year At €0.63

Recordati Industria Chimica e Farmaceutica's (BIT:REC) Dividend Will Be Increased To €0.63

Apr 25
Recordati Industria Chimica e Farmaceutica's (BIT:REC) Dividend Will Be Increased To €0.63

Recordati Industria Chimica e Farmaceutica S.p.A.'s (BIT:REC) Share Price Could Signal Some Risk

Apr 23
Recordati Industria Chimica e Farmaceutica S.p.A.'s (BIT:REC) Share Price Could Signal Some Risk

If EPS Growth Is Important To You, Recordati Industria Chimica e Farmaceutica (BIT:REC) Presents An Opportunity

Apr 08
If EPS Growth Is Important To You, Recordati Industria Chimica e Farmaceutica (BIT:REC) Presents An Opportunity

Recordati Industria Chimica e Farmaceutica (BIT:REC) Is Increasing Its Dividend To €0.63

Mar 23
Recordati Industria Chimica e Farmaceutica (BIT:REC) Is Increasing Its Dividend To €0.63

Is Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC) Expensive For A Reason? A Look At Its Intrinsic Value

Jan 27
Is Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC) Expensive For A Reason? A Look At Its Intrinsic Value

We Think Recordati Industria Chimica e Farmaceutica (BIT:REC) Can Stay On Top Of Its Debt

Jan 09
We Think Recordati Industria Chimica e Farmaceutica (BIT:REC) Can Stay On Top Of Its Debt

Risks To Shareholder Returns Are Elevated At These Prices For Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)

Dec 22
Risks To Shareholder Returns Are Elevated At These Prices For Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)

Recordati Industria Chimica e Farmaceutica (BIT:REC) Has Announced That It Will Be Increasing Its Dividend To €0.57

Nov 12
Recordati Industria Chimica e Farmaceutica (BIT:REC) Has Announced That It Will Be Increasing Its Dividend To €0.57

Is Recordati Industria Chimica e Farmaceutica (BIT:REC) Using Too Much Debt?

Sep 29
Is Recordati Industria Chimica e Farmaceutica (BIT:REC) Using Too Much Debt?

Estimating The Fair Value Of Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)

Sep 08
Estimating The Fair Value Of Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)

Here's Why Recordati Industria Chimica e Farmaceutica (BIT:REC) Can Manage Its Debt Responsibly

Jun 23
Here's Why Recordati Industria Chimica e Farmaceutica (BIT:REC) Can Manage Its Debt Responsibly

Does This Valuation Of Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC) Imply Investors Are Overpaying?

Jun 05
Does This Valuation Of Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC) Imply Investors Are Overpaying?

Recordati Industria Chimica e Farmaceutica's (BIT:REC) Conservative Accounting Might Explain Soft Earnings

Apr 08
Recordati Industria Chimica e Farmaceutica's (BIT:REC) Conservative Accounting Might Explain Soft Earnings

Recordati Industria Chimica e Farmaceutica (BIT:REC) Is Increasing Its Dividend To €0.60

Apr 05
Recordati Industria Chimica e Farmaceutica (BIT:REC) Is Increasing Its Dividend To €0.60

Recordati Industria Chimica e Farmaceutica (BIT:REC) Has Announced That It Will Be Increasing Its Dividend To €0.60

Mar 19
Recordati Industria Chimica e Farmaceutica (BIT:REC) Has Announced That It Will Be Increasing Its Dividend To €0.60

Here's Why Recordati Industria Chimica e Farmaceutica (BIT:REC) Can Manage Its Debt Responsibly

Mar 06
Here's Why Recordati Industria Chimica e Farmaceutica (BIT:REC) Can Manage Its Debt Responsibly

A Look At The Intrinsic Value Of Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)

Dec 23
A Look At The Intrinsic Value Of Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)

Is Recordati Industria Chimica e Farmaceutica (BIT:REC) A Risky Investment?

Dec 05
Is Recordati Industria Chimica e Farmaceutica (BIT:REC) A Risky Investment?

Recordati Industria Chimica e Farmaceutica (BIT:REC) Will Pay A Larger Dividend Than Last Year At €0.55

Nov 11
Recordati Industria Chimica e Farmaceutica (BIT:REC) Will Pay A Larger Dividend Than Last Year At €0.55

Recordati Industria Chimica e Farmaceutica S.p.A.'s (BIT:REC) Intrinsic Value Is Potentially 42% Above Its Share Price

Sep 01
Recordati Industria Chimica e Farmaceutica S.p.A.'s (BIT:REC) Intrinsic Value Is Potentially 42% Above Its Share Price

These 4 Measures Indicate That Recordati Industria Chimica e Farmaceutica (BIT:REC) Is Using Debt Reasonably Well

Aug 07
These 4 Measures Indicate That Recordati Industria Chimica e Farmaceutica (BIT:REC) Is Using Debt Reasonably Well

An Intrinsic Calculation For Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC) Suggests It's 25% Undervalued

Jun 03
An Intrinsic Calculation For Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC) Suggests It's 25% Undervalued

Recordati Industria Chimica e Farmaceutica (BIT:REC) Is Paying Out A Larger Dividend Than Last Year

May 16
Recordati Industria Chimica e Farmaceutica (BIT:REC) Is Paying Out A Larger Dividend Than Last Year

Recordati Industria Chimica e Farmaceutica (BIT:REC) Is Paying Out A Larger Dividend Than Last Year

May 02
Recordati Industria Chimica e Farmaceutica (BIT:REC) Is Paying Out A Larger Dividend Than Last Year

Recordati Industria Chimica e Farmaceutica's (BIT:REC) Shareholders Will Receive A Bigger Dividend Than Last Year

Apr 18
Recordati Industria Chimica e Farmaceutica's (BIT:REC) Shareholders Will Receive A Bigger Dividend Than Last Year

Recordati Industria Chimica e Farmaceutica (BIT:REC) Is Increasing Its Dividend To €0.57

Apr 04
Recordati Industria Chimica e Farmaceutica (BIT:REC) Is Increasing Its Dividend To €0.57

Recordati Industria Chimica e Farmaceutica (BIT:REC) Will Pay A Larger Dividend Than Last Year At €0.57

Mar 21
Recordati Industria Chimica e Farmaceutica (BIT:REC) Will Pay A Larger Dividend Than Last Year At €0.57

These 4 Measures Indicate That Recordati Industria Chimica e Farmaceutica (BIT:REC) Is Using Debt Reasonably Well

Mar 06
These 4 Measures Indicate That Recordati Industria Chimica e Farmaceutica (BIT:REC) Is Using Debt Reasonably Well

Calculating The Intrinsic Value Of Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)

Dec 22
Calculating The Intrinsic Value Of Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)

Recordati Industria Chimica e Farmaceutica (BIT:REC) Has A Pretty Healthy Balance Sheet

Dec 05
Recordati Industria Chimica e Farmaceutica (BIT:REC) Has A Pretty Healthy Balance Sheet

Estimating The Intrinsic Value Of Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)

Sep 23
Estimating The Intrinsic Value Of Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)

Is Recordati Industria Chimica e Farmaceutica (BIT:REC) A Risky Investment?

Sep 05
Is Recordati Industria Chimica e Farmaceutica (BIT:REC) A Risky Investment?

A Look At The Fair Value Of Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)

Jun 25
A Look At The Fair Value Of Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)

Here's Why Recordati Industria Chimica e Farmaceutica (BIT:REC) Can Manage Its Debt Responsibly

Jun 07
Here's Why Recordati Industria Chimica e Farmaceutica (BIT:REC) Can Manage Its Debt Responsibly

Earnings Miss: Recordati Industria Chimica e Farmaceutica S.p.A. Missed EPS By 8.5% And Analysts Are Revising Their Forecasts

May 10
Earnings Miss: Recordati Industria Chimica e Farmaceutica S.p.A. Missed EPS By 8.5% And Analysts Are Revising Their Forecasts

Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC) Shares Could Be 34% Above Their Intrinsic Value Estimate

Mar 11
Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC) Shares Could Be 34% Above Their Intrinsic Value Estimate

Here's What You Should Know About Recordati Industria Chimica e Farmaceutica S.p.A.'s (BIT:REC) 2.4% Dividend Yield

Feb 19
Here's What You Should Know About Recordati Industria Chimica e Farmaceutica S.p.A.'s (BIT:REC) 2.4% Dividend Yield

Recordati Industria Chimica e Farmaceutica S.p.A.'s (BIT:REC) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Jan 30
Recordati Industria Chimica e Farmaceutica S.p.A.'s (BIT:REC) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Gelir ve Gider Dağılımı

Recordati Industria Chimica e Farmaceutica nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

BIT:REC Gelir, gider ve kazançlar (EUR Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Jun 242,224387627276
31 Mar 242,139389608263
31 Dec 232,082389602256
30 Sep 232,032375600247
30 Jun 232,005389601240
31 Mar 231,985340601237
31 Dec 221,853312572220
30 Sep 221,801331546202
30 Jun 221,702330517184
31 Mar 221,615393489168
31 Dec 211,580386481166
30 Sep 211,511377459160
30 Jun 211,460365442156
31 Mar 211,404334417153
31 Dec 201,449355422146
30 Sep 201,475389431144
30 Jun 201,499391438141
31 Mar 201,528388452135
31 Dec 191,482369446130
30 Sep 191,439328428122
30 Jun 191,399322414116
31 Mar 191,369318405111
31 Dec 181,352312401110
30 Sep 181,338307400108
30 Jun 181,333306400107
31 Mar 181,313297399105
31 Dec 171,288289397100
30 Sep 171,25527539196
30 Jun 171,21726238589
31 Mar 171,19425038085
31 Dec 161,15423736984
30 Sep 161,12622936382
30 Jun 161,09621835780
31 Mar 161,07421235579
31 Dec 151,04819935277
30 Sep 151,03019035079
30 Jun 151,01918134982
31 Mar 151,00317034484
31 Dec 1498716134185
30 Sep 1498215633881
30 Jun 1497214633477
31 Mar 1495713933377
31 Dec 1394213433075

Kaliteli Kazançlar: REC has high quality earnings.

Büyüyen Kar Marjı: REC's current net profit margins (17.4%) are lower than last year (19.4%).


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: REC's earnings have grown by 1.1% per year over the past 5 years.

Büyüme Hızlandırma: REC's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Kazançlar vs. Sektör: REC had negative earnings growth (-0.4%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (4.5%).


Özkaynak Getirisi

Yüksek ROE: REC's Return on Equity (21.4%) is considered high.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin